ATE448792T1
Use of botulinum toxin for the treatment of recalcitrant voiding dysfunction
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 15 July 2018, 8.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
151 members in 16 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 5258097 | United States of America | P |
Members151
| Document | Office | Kind | |
|---|---|---|---|
| CA2296720A1 | Canada | A1 | |
| CA2505930A1 | Canada | A1 | |
| CA2505933A1 | Canada | A1 | |
| CA2521392A1 | Canada | A1 | |
| CA2570406A1 | Canada | A1 | |
| WO9903483A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8300798A | Australia | A | |
| EP1011695A1 | European Patent Office (EPO) | A1 | |
| CN1270527A | China | A | |
| KR20010021941A | Republic of Korea | A | |
| JP2001510163A | Japan | A | |
| AU743085B2 | Australia | B2 | |
| US2002025327A1 | United States of America | A1 | |
| US6365164B1 | United States of America | B1 | |
| US6667041B2 | United States of America | B2 | |
| CN1135988C | China | C | |
| CN1480212A | China | A | |
| EP1011695A4 | European Patent Office (EPO) | A4 | |
| US2004126380A1 | United States of America | A1 | |
| US2004180065A1 | United States of America | A1 | |
| EP1475099A1 | European Patent Office (EPO) | A1 | |
| US2004259788A1 | United States of America | A1 | |
| HK1064044A | Hong Kong, China | A | |
| HK1064044A1 | Hong Kong, China | A1 | |
| EP1502601A1 | European Patent Office (EPO) | A1 | |
| US2005048084A1 | United States of America | A1 | |
| US2005049175A1 | United States of America | A1 | |
| JP2005089478A | Japan | A | |
| JP2005089479A | Japan | A | |
| US2005112147A1 | United States of America | A1 | |
| US2005159337A1 | United States of America | A1 | |
| CN1651074A | China | A | |
| JP3692033B2 | Japan | B2 | |
| AU2005234633A1 | Australia | A1 | |
| EP1475099B1 | European Patent Office (EPO) | B1 | |
| AT314085T | Austria | T | |
| ATE314085T1 | Austria | T1 | |
| KR100544060B1 | Republic of Korea | B1 | |
| DE69833059D1 | Germany | D1 | |
| US7001602B2 | United States of America | B2 | |
| JP2006063089A | Japan | A | |
| DK1475099T3 | Denmark | T3 | |
| EP1011695B1 | European Patent Office (EPO) | B1 | |
| EP1637157A1 | European Patent Office (EPO) | A1 | |
| AT320815T | Austria | T | |
| ATE320815T1 | Austria | T1 | |
| JP2006104221A | Japan | A | |
| HK1080377A | Hong Kong, China | A | |
| HK1080377A1 | Hong Kong, China | A1 | |
| DK1011695T3 | Denmark | T3 | |
| DE69833942D1 | Germany | D1 | |
| EP1658858A2 | European Patent Office (EPO) | A2 | |
| ES2255025T3 | Spain | T3 | |
| EP1658858A3 | European Patent Office (EPO) | A3 | |
| ES2256945T3 | Spain | T3 | |
| CN1803189A | China | A | |
| PT1011695E | Portugal | E | |
| DE69833059T2 | Germany | T2 | |
| DE69833942T2 | Germany | T2 | |
| EP1502601B1 | European Patent Office (EPO) | B1 | |
| AT339220T | Austria | T | |
| ATE339220T1 | Austria | T1 | |
| DE69835911D1 | Germany | D1 | |
| US7153514B2 | United States of America | B2 | |
| PT1502601E | Portugal | E | |
| DE69835911T2 | Germany | T2 | |
| DK1502601T3 | Denmark | T3 | |
| HK1091750A | Hong Kong, China | A | |
| HK1091750A1 | Hong Kong, China | A1 | |
| ES2268567T3 | Spain | T3 | |
| CN1939531A | China | A | |
| JP2007091756A | Japan | A | |
| AU2005234633B2 | Australia | B2 | |
| JP2007126477A | Japan | A | |
| CN1321683C | China | C | |
| JP3955061B2 | Japan | B2 | |
| CA2296720C | Canada | C | |
| CA2505930C | Canada | C | |
| JP4053559B2 | Japan | B2 | |
| US2008177248A1 | United States of America | A1 | |
| EP1949909A1 | European Patent Office (EPO) | A1 | |
| JP2008208136A | Japan | A | |
| CA2505933C | Canada | C | |
| US7429387B2 | United States of America | B2 | |
| US7449192B2 | United States of America | B2 | |
| US7455845B2 | United States of America | B2 | |
| US7470431B2 | United States of America | B2 | |
| US2009004312A1 | United States of America | A1 | |
| US2009028974A1 | United States of America | A1 | |
| HK1119396A | Hong Kong, China | A | |
| HK1119396A1 | Hong Kong, China | A1 | |
| US2009068227A1 | United States of America | A1 | |
| CN100518816C | China | C | |
| AU2005234633B9 | Australia | B9 | |
| EP1011695B2 | European Patent Office (EPO) | B2 | |
| EP1658858B1 | European Patent Office (EPO) | B1 | |
| AT448792T | Austria | T | |
| ATE448792T1This record | Austria | T1 | |
| DE69841291D1 | Germany | D1 | |
| EP2145629A2 | European Patent Office (EPO) | A2 |
Showing 100 of 151
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5024445
Titles2
- German
- VERWENDUNG VON BOTULINUMTOXIN ZUR BEHANDLUNG DER RENITENTEN BLASENENTLEERUNGSSTÖRUNG
- English
- USE OF BOTULINUM TOXIN TO TREAT RETIRED BLADDER DISORDER
Classification
- CPC, 23
- A61K38/4893
- A61K35/00
- A61K31/165
- A61K31/529
- A61K38/1703
- A61P1/04
- A61P13/00
- A61P13/02
- A61P13/08
- A61P13/10
- A61P15/00
- A61P17/10
- A61P21/00
- A61P25/00
- A61P25/02
- A61P25/16
- A61P29/00
- A61P31/00
- A61P35/00
- A61P5/24
- A61P7/10
- A61P7/12
- A61P9/00
- IPC, 13
- A61K9 00
- A61K9 08
- A61K31 165
- A61K35 74
- A61K38 00
- A61K38 16
- A61K38 48
- A61K45 00
- A61P13 00
- A61P13 02
- A61P13 08
- A61P13 10
- A61P15 00